Cargando…
Use of proton pump inhibitor may be associated with progression of cerebral small vessel disease
Proton pump inhibitors (PPIs) are widely used for the treatment of gastrointestinal diseases. However, recent studies have shown that chronic PPI use is associated with the progression of endothelial senescence and cerebrovascular diseases. We hypothesized that PPI users might be vulnerable to fast...
Autores principales: | Kang, Min Kyoung, Shin, Jung Hwan, Kim, Tae Jung, Lee, Ji Sung, Yoon, Byung-Woo, Ko, Sang-Bae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770424/ https://www.ncbi.nlm.nih.gov/pubmed/36542643 http://dx.doi.org/10.1371/journal.pone.0279257 |
Ejemplares similares
-
Neutrophil-to-lymphocyte ratio predicts early worsening in stroke due to large vessel disease
por: Nam, Ki-Woong, et al.
Publicado: (2019) -
Temperature Dependency of Proton Pumping Activity for Marine Microbial Rhodopsin from Antartic Ocean
por: Kim, Se-Hwan, et al.
Publicado: (2020) -
Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers
por: Jung, Da Hyun, et al.
Publicado: (2021) -
Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma
por: Lee, Yoo-Young, et al.
Publicado: (2015) -
Progress with proton pump inhibition.
por: Bell, N. J., et al.
Publicado: (1992)